Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
Address:
9 Jeffrey orchard
NW1 North Joshuaville (United Kingdom)
ID: 8029-862360-6 (ECI)
Report
Date: 01-JUL-2024
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 01-JUL-2024

Hematology

Test 01-JUL-2024 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 6.1 3.6 - 10.5 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.9 4.3 - 6.1 10*6/uL
Hemoglobin [Mass/volume] in Blood 12.4 L 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 47.0 38 - 50 %
MCV [Entitic volume] by Automated count 80.0 76 - 98 fL
MCH [Entitic mass] by Automated count 31.2 27 - 33 pg
MCHC [Mass/volume] by Automated count 35.4 31 - 37 g/dL
Erythrocyte distribution width [Ratio] by Automated count 12.4 11.6 - 16.5 %
Platelets [#/volume] in Blood by Automated count 381.9 155 - 415 10*3/uL

Chemistry

Test 01-JUL-2024 Reference Range Unit
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 1004.9 H 300 - 900 pg/mL
Glucose [Mass/volume] in Serum or Plasma 192.0 H 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 14.2 7 - 50 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 0.7 L 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Serum or Plasma 140.6 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 102.8 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 27.0 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.9 6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.7 3.5 - 5.5 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 75.8 40 - 117 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 10.9 10 - 66 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23.5 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 2.3 1.6 - 2.6 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 247.1 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 426.7 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 139.0 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 22.8 L 40 - 100 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 0.0 0 - 19.9 pg/mL
Ferritin [Mass/volume] in Serum or Plasma 138.9 30 - 300 ug/L
Iron [Mass/volume] in Serum or Plasma 154.7 65 - 300 ug/dL
Iron binding capacity [Mass/volume] in Serum or Plasma 335.9 250 - 450 ug/dL
Iron saturation [Mass Fraction] in Serum or Plasma 40.0 15 - 45 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated NT-proBNP, suggesting possible heart failure or cardiac strain. There is mild normocytic anemia. Glucose is acutely elevated, but HbA1c is within normal range, indicating possible stress hyperglycemia. Lipid profile is atherogenic (high total cholesterol, LDL, triglycerides, and low HDL). Renal and liver function are within normal limits. No acute myocardial injury is detected. Recommend clinical correlation for cardiac status and metabolic risk management.